Expression of both ESRRA and PPARGC1A was suppressed in TIRM+ muscle compared to control (Fig. 3C and D), confirming our in vitro findings [69] in FSHD patients. The gene discussed is PPARGC1A; the disease is facioscapulohumeral muscular dystrophy.